Lithium Universe Ltd (ASX:LU7, OTC:LUVSF) has signed a cooperation MOU with Hsinchu-based PV recycler RePV Tech to combine RePV’s delamination know-how with LU7’s Microwave Joule Heating Technology (MJHT) and JESE silver-extraction systems, run joint trials aimed at recovering high-purity “Britannia-grade” silver from solar-panel waste, and channel shared data under agreed IP protections toward a defined commercialisation pathway. As part of the program, RePV Tech will supply recycled silicon wafers for testing at Macquarie University laboratories, with the collaboration targeting circular-economy outcomes by converting end-of-life solar modules into valuable metal resources.
RePV Tech, established under licence from Taiwan’s Industrial Technology Research Institute (ITRI), is a leader in solar-module recycling with an “easy dismantling” process that separates glass from silicon wafers — an alternative to LU7’s MJHT approach to PV delamination. The company also recovers multiple valuable materials from discarded cells. Lithium Universe said the partnership aligns complementary technologies to improve recovery rates and purity while safeguarding IP and enabling future scaling.
Lisata Therapeutics Inc (NASDAQ:LSTA) has reported financial results for the third quarter, highlighting continued clinical progress for its lead investigational therapy, certepetide, and announcing strategic collaborations to expand its development and discovery capabilities.
Certepetide, Lisata’s proprietary investigational peptide, continues to be studied across multiple solid tumor types in combination with standard anti-cancer therapies.
AMC Entertainment Holdings (NYSE:AMC) delivered better-than-expected financial results for the third quarter, driven by market share gains and strong per-customer spending, though profitability declined compared with a year earlier.
The company posted revenue of $1.3 billion, down from $1.35 billion in the year-ago quarter but topping analyst estimates of $1.23 billion.
Happy Creek Minerals Ltd. (TSX-V:HPY, OTC:HPYCF) announced that Stephen Gray will assume the roles of CEO and director, taking the lead as the company advances its exploration programs amid strong market sentiment for tungsten.
Gray succeeds Jason Bahnsen, who has resigned from the board and as CEO, effective Thursday.
Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF) has announced its 2026 exploration plans and provided a summary of its 2025 exploration activities across its uranium projects in the Athabasca Basin, northern Saskatchewan.
The company said its 2026 programs will include high-resolution geophysics and targeted diamond drilling across multiple projects, including its flagship Davidson River property and partner-funded programs at the Corvo and Rocas projects.
Lisata Therapeutics Inc (NASDAQ:LSTA) announced that it has won the “Overall BioPharma Solution of the Year” in the fifth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, an independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services throughout the world.
The clinical-stage pharmaceutical company said the award is in recognition of its unique therapeutic approach and focused clinical development plans, designed to produce products to address the unmet medical needs of patients with advanced solid tumors.
Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF) announced that its third quarter 2025 average daily sales rose 11% year over year to 2,343 barrels of oil equivalent per day (boepd).
The oil and gas junior also generated funds flows from operations of US$10.4 million during the quarter, or US$0.28 per share, an increase of US$0.6 million from the same period last year.
Argentina Lithium & Energy Corp (TSX-V:LIT, OTCQX:LILIF) said it has made significant technical and strategic progress over the past year as it moves towards its goal of becoming a leading producer of battery-grade lithium within Argentina’s Lithium Triangle.
In a letter to shareholders, CEO Nikolaos Cacos said the company’s flagship Rincon West lithium brine project in Salta Province remains the centerpiece of its growth strategy.
Algernon Health (CSE:AGN, OTCQB:AGNPF) announced that it plans to raise up to $500,000 through a non-brokered private placement of units priced at $0.07 each.
The proceeds from the financing will be used to advance the company’s Alzheimer’s disease research program, including preparations to open its first US brain-specific neuroimaging clinic.
Seeing Machines Ltd's (AIM:SEE, OTC:SEEMF) shares jumped 7% to 3.68p after the in-car safety specialist announced growing traction in China through its partnership with auto parts giant Magna and a leading German carmaker.
The AIM-listed company said Magna’s integrated mirror system, which embeds Seeing Machines’ driver and occupant monitoring technology, has now completed its first full year of large-scale production in China, a major milestone for the group.
Ethernity Networks Ltd (AIM:ENET, OTCQB:ENETF) shares dropped 31.25% to 0.0083p after the company announced a heavily dilutive £342,500 fundraising and called an extraordinary general meeting to approve changes to its share capital structure.
The fundraising includes a £160,000 placing of over 711 million new shares at 0.02249p per share – a premium to the previous closing price – and a £182,500 convertible loan note (CLN).
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) said its in-car safety technology is gaining momentum in China through its collaboration with automotive supplier Magna and a major German carmaker.
The AIM-listed company, which develops artificial intelligence-powered systems that track driver alertness and behaviour, said the partnership marks a “significant milestone” as Magna’s integrated mirror system.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) said it is evaluating a dual primary listing of its shares on the main board of the Hong Kong Stock Exchange as part of plans to expand its footprint in Asia.
The biotechnology group, which is already listed on London’s AIM market, said the move would aim to broaden its investor base and boost liquidity in its shares.
Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) has fired up the rigs at its flagship Mt York Gold Project in Western Australia, launching a 10,000-metre reverse circulation and diamond drilling program aimed at extending its 1.4-million-ounce resource base.
The campaign follows Kairos’ recently executed Mineral Rights Agreement with Pilbara Minerals Ltd (ASX:PLS), allowing the company to drill across the adjacent PLS-owned licence (E45/2241), where historic reconnaissance drilling has already returned promising gold intercepts.
Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) has outlined a string of high-grade rock chip results and fresh targets from reconnaissance work at its Tibooburra Gold Project in New South Wales, headlined by 39.9 g/t gold at Pioneer North and multiple standout assays at Pioneer South, where seven of 20 samples topped 4 g/t with a peak of 19.8 g/t. Recent mapping, down-hole televiewer and acoustic surveys at Clone, and core re-logging from Pioneer and New Bendigo point to shallow to moderate NNW-plunging high-grade shoots as the primary target style across the field.
Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) has secured 189 BCFe of newly certified 2C Contingent Gas Resources (100% net to EXR) in ATP2077 Block-B on the western flank of the Taroom Trough, independently verified by Sproule ERCE. This addition lifts Elixir’s total independently certified 2C resources in the Taroom Trough Basin-Centred Gas Play to ~2.8 TCFe (2,792 BCFe) — an 8% increase that highlights the scale and quality of the company’s acreage.
“The addition of this new Contingent Gas Resource is material in its own right, but when added to the company’s existing independently certified gas resources, it highlights the scale and the impact that the Taroom Trough may have on full commercialisation,” Elixir Energy managing director and CEO Stuart Nicholls said.